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ABSTRACT

Malignant catarrhal fever (MCF) is a lymphoproliferative and inflammatory syndrome
affecting primarily ruminant species. The disease, which is often fatal, is most often
described as affecting bovids and cervids. No vaccines are available for prevention of
MCFV infection. The primary method to control spread of disease is to prevent contact
between carriers and clinically susceptible species. There is no known method to
control infection of malignant catarrhal fever virus-white-tailed deer variant (MCFVWTD), as the carrier animal of this virus is unknown.
To determine the prevalence of malignant catarrhal fever viruses in Tennessee
ruminant populations, blood and/or lymph node samples were collected from farms,
animal processing and disposal facilities, and hunter check-in stations from 2006-2008
from several species of animals including cervids, cattle, and goats. Strain-specific real
time PCR was developed to detect ovine herpesvirus-2 (OvHV-2), caprine herpesvirus2 (CpHV-2), and MCFV-WTD DNA. MCFV DNA was detected in all species of
ruminants sampled. Although disease related to infection with MCFV-WTD and CpHV-2
has not been reported in Tennessee cattle or cervid populations, MCFV-WTD DNA was
detected in 3 percent of cervid samples, and MCFV-WTD and CpHV-2 DNA was
detected in 27 and 3 percent respectively of cattle samples from animal disposal
facilities that process dead or debilitated animals. One hunter harvested deer (n=781)
and 25 cattle (n=165) tested from animal disposal facilities were positive for OvHV-2
DNA.
v

This study demonstrated that healthy cattle and cervids can be infected with OvHV-2
and MCFV-WTD without apparent disease, and dead or debilitated cattle were infected
with OvHV-2, MCFV-WTD and CpHV-2 at a higher percentage than healthy herd
animals. Prevalence of CpHV-2 in Tennessee goat populations (7%) was significantly
lower than reported in other goat populations (73%). Low prevalence of CpHV-2 in
Tennessee goat populations likely explains why no evidence of infection was found in
cervids tested, and the low prevalence of CpHV-2 infection in dead or debilitated cattle
compared to prevalence of infection with OvHV-2 and MCFV-WTD. The discovery of
infection in cattle with CpHV-2 and MCFV-WTD opens a new avenue of investigation
into the pathology and virulence of MCFV’s in domestic cattle.
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Chapter 1. Literature Review
Malignant catarrhal fever – Introduction
Malignant catarrhal fever (MCF) is a lymphoproliferative and inflammatory
syndrome that primarily affects ruminant species. The disease, which is often
fatal, has been most often described as affecting bovids, cervids, and certain
other susceptible ruminant species, but is also recognized in domestic pigs
(Bedelian, 2007; OIE, 2004), and has been shown experimentally in rabbits
(Rossiter et al., 1977, 1978). Outbreaks of malignant catarrhal fever occur
sporadically in all continents, and are attributed to large economic losses in
domestic cattle, deer and bison herds (Berezowski et al., 2005; Brown and Bloss,
1992; Dabak and Bulut, 2003; Hamilton, 1990; Li et al., 2008; Li et al., 2006;
O'Toole et al., 2002). Carrier animals have been identified and are believed to
be the source of the disease in affected ruminants (Baxter et al., 1997; Li et al.,
1995; Plowright et al., 1960). There are many strains of virus that cause this
disease in susceptible species, all of which belong to the Herpesviridae subfamily
Gammaherpesviridae.

Gammaherpesviruses
The host range of the Gammaherpesvirinae subfamily is primarily limited to the
family or orders to which the natural host belongs. As with all viruses in the
Herpesviridae family, their genomes are composed of linear double stranded
1

DNA. The genomic DNA is packed into an icosohedral capsid which is
embedded in a complex amorphous layer composed of several proteins called
the tegument. The entire structure is then enclosed by a glycoprotein containing
lipid envelope (McGeoch et al., 2006). Viruses in the Gammaherpesvirinae
subfamily are usually specific for T or B lymphocytes, and latency is frequently
established in lymphoid tissue (Fields et al., 2001). Unlike alpha or beta herpes
viruses, which seem to prefer lytic replication, gammaherpesviruses seem to
favor the initial establishment of latency, while only a subset support lytic
replication. The outcome of infections with the gammaherpesviruses depends not
only on the virus but also the targeted animal. In vivo, viruses in this subfamily
have evolved with their reservoir hosts to actively protect their latently infected
cells from being destroyed by the hosts’ immune response. Hosts have evolved
to being infected and can transmit the viruses without showing symptoms of overt
disease. In animals not adapted to infection, such as in animals that did not coevolve with the virus, the development of lethal diseases such as malignant
catarrhal fever or Kaposi’s sarcoma occurs (Ackermann, 2006). In recent years
many new gammaherpesviruses have been discovered and classified (McGeoch
et al., 2005).
The Gammaherpesvirinae subfamily has been traditionally divided into two
genera: Lymphocryptovirus and Rhadinovirus (Fields et al., 2001). The
Lymphocryptovirus genus contains Epstein-Barr virus, and several other
lymphocryptoviruses of primates. The Rhadinovirus genus contains herpes2

viruses with hosts of many mammalian taxa. Many of these viruses are of
interest for medicine, veterinary medicine and biomedical research (Ackermann,
2006). There are many similarities between the two genomes. Given these
similarities and the restriction of lymphocrytoviruses to primates, it is proposed
that lymphocryptoviruses may have evolved from an early primate rhadinovirus
(Knipe et al., 2001).
Gammaherpesviruses share many genes with limited or less obvious
representation in the genomes of other herpes viruses. These include genes that
encode several immediate-early or early regulators of viral gene expression, an
anti-apoptotic Bcl-2 homolog, and two integral membranes (Knipe et al., 2001).
Lymphocryptoviruses and rhadinoviruses have analogous, nonhomologous cisacting DNA sequences and transacting nuclear proteins necessary for
persistence of the genomes as episomes in dividing cells. The genomes of the
lymphocryptoviruses and rhadinoviruses are much more related to each other
than to other alpha or beta herpesviruses (Knipe et al., 2001).
Rhadinoviruses
Most rhadinoviruses have cellular genes including dihydrofolate
reductase, interferon regulator factors, G-protein coupled receptors,
chemokine analogs, and a cyclin homolog in common. These genes
have not been detected in lymphocryptoviruses. Unlike lymphocryptoviruses, rhadinoviruses are unable to immortalize B lymphocytes of
3

their natural host (Knipe et al., 2001). Malignant Catarrhal fever
viruses have traditionally been characterized as rhadinoviruses,
although in recent years it has been proposed that a new genus, the
Macaviruses, be established in the gammaherpesvirus subfamily, and
that these viruses be placed in this family (McGeoch et al., 2006).
Several viruses have been identified within the MCF virus group, four
of which: alcelaphine herpesvirus-1, ovine herpesvirus-2, caprine
herpesvirus-2, and malignant catarrhal fever virus white-tailed deer
variant, are known to be pathogenic (Li et al., 2003a).

Malignant Catarrhal Fever viruses as Interface diseases
The interaction of domestic animals and wildlife is increasingly becoming an
issue of concern with regard to the spread and emergence of infectious animal
diseases. Many important animal diseases cross-infect domestic animals and
wildlife. These animals may interface in places such as fence lines, shared
habitat and ranges, common water sources, and live animal markets (Bengis et
al., 2002) (Fevre et al., 2006).
Many diseases are believed to be maintained in a region through infection of
wildlife and domestic livestock. There has been a long-standing conflict between
livestock owners and animal health authorities, as well as wildlife
conservationists, regarding controlling diseases of livestock associated with
wildlife. It is important to realize that where animals interface, transmission of
4

pathogens can be bidirectional: from wild to domestic animals, as well as
domestic to wild animals (Bengis et al., 2002). This bidirectional transmission of
pathogens allows a disease agent to maintain a cycle within a region, making it
difficult to eradicate or control. The following malignant catarrhal fever viruses
are most commonly associated with disease (Li et al., 2003a). The cycle of
disease transfer which occurs in the spread of these viruses relies upon the
interface between domestic and wildlife species.
Wildebeest-Associated Malignant Catarrhal Fever
Etiology
The virus known to cause malignant catarrhal fever in African
bovids, alcelaphine herpesvirus-1, was first isolated from the
leukocytes, spleen and lymph node suspensions of a blue
wildebeest and described as being a herpesvirus in 1960 by
Plowright and associates. Initially designated Bovid Herpesvirus 3
and believed to be similar to the betaherpesviruses (Roizman,
1973) (Plowright et al., 1960), it was later discovered to most
closely resemble viruses associated with the gammaherpesvirus
family (Rossiter et al., 1983b), (Mushi and Rurangirwa, 1981).
Malignant catarrhal fever had been shown to occur in cattle after
close association with apparently healthy blue or black wildebeests
(Daubney, 1936; Mettam, 1923), but prior to the work by Plowright
5

and associates, the etiologic agent had not been identified or
isolated. Having a method to obtain cell-free virus for use in
experiments and development of diagnostics allowed for greater
characterization of AlHV-1. In additional to this, the entire genome
was sequenced in 1997 (Ensser et al., 1997).
Transmission of disease
First believed only to exist as a cell-associated virus (Rweyemamu
et al., 1974) (Plowright et al., 1960), it was later discovered that it
could survive as cell free virus and be passed in this form to cattle
by nasal secretions of wildebeest (Mushi et al., 1981). It was also
shown to be vertically transmitted to offspring transplacentally,
when virus was isolated from the spleen of a fetus (Plowright et al.,
1960). The main source of infection appears to be the wildebeest
calf (Plowright, 1965), as virus has primarily been isolated from the
ocular and nasal secretions of young wildebeest less than 3
months, and virtually all animals are infected by age 4 months
(Barnard et al., 1989a; Mushi et al., 1980). Viral shedding in adults
appears to be quite low, and occurs primarily during periods of
stress or parturition (Barnard et al., 1989a; Rweyemamu et al.,
1974). Originally, fetal membranes and fluids were also believed to
be a major source of infection to cattle, but virus was not isolated
6

from either material (Rossiter et al., 1983a). It has been proposed
that the membranes and fluids act as markers for pastureland
which is heavily contaminated with malignant catarrhal fever virus
from oculonasal secretions of wildebeest calves, therefore cattle
should not be grazed at these locations (Rossiter et al., 1983a).
In Kenya and Tanzania, wildebeest associated MCF occurs
primarily during calving season ((Mushi and Rurangirwa, 1981), but
in South Africa disease occurs most often during the late winter and
early spring, when calves are 8-10 months old (Barnard et al.,
1989a). In zoological parks sporadic cases of wildebeest
associated MCF can appear throughout the year (Castro et al.,
1984; Hanichen et al., 1998).
AlHV-1 is not transmitted from one clinically susceptible host to
another via natural methods, as the virus secreted from non-host
animals is cell-associated and therefore extremely labile (Mushi
and Rurangirwa, 1981; Plowright, 1968). As such, sick animals
may be housed with healthy animals without fear of horizontal
disease transmission (Plowright, 1965). In some instances it is
possible for cattle to transmit the virus to their offspring
transplacentally (Plowright et al., 1972).

7

Pathology
The length of incubation required to cause disease differs among
species. Reports from studies of experimental exposure estimate
incubation to last from 9 to 60 days or longer (Hatkin, 1980;
Plowright, 1968; Plowright et al., 1960). In some instances,
animals may recover from subclinical infection and the virus may
recrudesce several months later (Heuschele et al., 1985). The
disease caused by AlHV-1 is characterized by corneal opacity,
erosions on the oral epithelium, salivation, anorexia, a
mucopurulent nasal discharge, and increased body temperature
and is typically referred to as the “head and eye” form of MCF
(Pierson et al., 1979).

Upon histologic examination, lympho-

proliferation and generalized necrotizing vasculitis are the most
commonly recognized signs (Metzler, 1991; Plowright, 1986).
Sheep-Associated Malignant Catarrhal Fever
Etiology
For almost a century, sheep were believed to be the source of nonwildebeest associated malignant catarrhal fever (Götze, 1930;
Götze, 1929), but all attempts to isolate the causative agent were
unsuccessful (Plowright, 1968; Selman et al., 1974). Attempts to
understand the etiology and epidemiology of the agent causing this
8

disease have therefore been less direct than methods used with
wildebeest strains. Lymphoblastoid cells have been propagated
from cattle, deer and rabbits with sheep-associated malignant
catarrhal fever (Reid et al., 1989; Reid et al., 1983; Schuller et al.,
1990). One of these cell lines was used to construct a genomic
library, and a clone from this library hybridized to cloned
alcelaphine herpesvirus-1 DNA (Bridgen and Reid, 1991). From
this it was suggested that the viral agent of sheep-associated
malignant catarrhal fever and alcelaphine herpesvirus-1 are closely
related gammaherpesviruses and the virus was named ovine
herpesvirus-2 (OvHV-2) (Roizmann et al., 1992). Development of
molecular techniques such as polymerase chain reaction has led to
a greater understanding of OvHV-2. In 2007 the entire genome
was published (Hart et al., 2007). Prior to that, inferences were
made into how the virus reacted in a susceptible host based upon
genes detected using molecular techniques (Coulter and Reid,
2002; Thonur et al., 2006).
Transmission of disease
Virtually all domestic sheep are believed to be infected with ovine
herpesvirus-2 (Baxter et al., 1997; Li et al., 1995). Transmission of
this virus occurs primarily from sheep after 3 months of age (Li et
9

al., 2001a). The majority of viral shedding comes from adolescent
lambs, age 6 to 9 months. In general, the pattern of the
appearance of viral DNA in nasal secretions occurred as a dramatic
rise and subsequent fall within 24 to 36 hours. In adolescent
sheep, this can occur multiple times between the ages of 6 and 9
months (Li et al., 2001a; Li et al., 2004). The frequency of viral
shedding declines past the age of 9 months (Li et al., 2001a).
Shedding episodes in adult sheep occur much less frequently than
shedding in adolescent lambs (Li et al., 2001a; Li et al., 2004).
Unlike wildebeest associated malignant catarrhal fever, shedding of
the virus does not seem to be associated with lambing, and no
seasonal trend in viral shedding of adult sheep has been identified
(Barnard et al., 1994; Li et al., 2001a). This suggests that the
likelihood of transmission from an adult sheep to a susceptible host
occurs at a relatively stable, albeit infrequent, rate. Horizontal
transfer between clinically ill cattle has not been shown in field
observations and experimental data (Farquarson, 1946; Mare,
1977; Plowright, 1990).
Bali cattle, Asian swamp buffalo, the American bison, and deer
species are reported to be more susceptible to disease caused by
ovine herpesvirus-2 than Bos taurus and Bos indicus cattle species
(Clark et al., 1970; Daniels et al., 1988; Hamilton, 1990; O'Toole et
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al., 2002; Reid et al., 1987; Schultheiss et al., 2000). In general,
cattle are regarded to be less susceptible to disease caused by
OvHV-2 than AlHV-1 (Loken et al., 2009).
Pathology
In most cases, disease in cattle caused by OvHV-2 is virtually
indistinguishable from the syndrome produced from infection with
AlHV-1. Skin lesions occur more often in cattle and deer infected
with the OvHV-2 strain than with AlHV-1 strain (Plowright, 1990).
In deer, the syndrome appears to be peracute or acute, and
animals succumb within 12 hours of onset of elevated temperature,
mild diarrhea and inappetence without developing the characteristic
signs of the disease (Reid, 1991), although some deer have
developed acute haemorrhagic enteritis followed rapidly by death
(Wilson et al., 1983). Bison appear to be one of the most highly
susceptible animals to disease when infected with OvHV-2. Clinical
onset of disease appears to be acute, with death coming within 1-3
days of onset (O'Toole et al., 2002), although chronic cases do
occur (Schultheiss et al., 1998). Mortality in exposed bison herds is
usually quite high (Schultheiss et al., 2000), although it has been
shown definitively that bison do not spread virus to herdmates, as
animals in an outbreak exposed prior to being added to an existing
11

herd of bison were the only animals exhibiting morbidity, even when
51% of animals succumbed to disease (n=825/1610) (Li et al.,
2006). Goats can be infected with OvHV-2 (Li et al., 2001b), but
disease associated with infection has not been reported.
Goat-Associated Malignant Catarrhal Fever
Etiology
In recent years, goats have been believed to be a source of
malignant catarrhal fever virus where sheep and wildebeest were
not present, but the agent of infection was believed to be OvHV-2
(Li et al., 1996; Wiyono et al., 1994). In 2001, a study was
published by Li and coworkers in which a novel gammaherpesvirus
in domestic goats was identified, and the two viruses reported
appear to be the same (Li et al., 2001b). This virus was identified
when OvHV-2-specific PCR failed to detect viral DNA in MCFV
seropositive goats (antibody detected utilizing the CI-ELISA).
Amplification product generated by degenerative primer PCR (Li et
al., 2000) was analyzed and determined to be 71% identical to
OvHV-2, 67% identical to AlHV-1, and 73% identical to MCFVWTD. Based upon this information, the virus was characterized as
a new member of the MCF group of viruses and designated caprine
herpesvirus-2. At the same time as the Li study, Chmielewicz and
12

associates detected a herpesvirus in an apparently healthy pig, and
the source of this virus was determined to be a goat housed with
the animal. Upon analysis, it was observed that this virus also had
high identity with OvHV-2 and AlHV-2, and was also characterized
as a gammaherpesvirus and designated caprine herpesvirus-2
(Chmielewicz et al., 2001). The two viruses, which were
characterized at the same time, appear to be the same.
Transmission of disease
The transmission pattern in goats of the virus appear to be similar
to that of OvHV-2 in sheep, as kids separated from the herd at one
week of age did not become infected with the virus, and adult goats
were susceptible to CpHV-2 (Li et al., 2005).
Pathology
To date disease associated with infection of CpHV-2 has only been
documented in cervid species, including white-tailed deer, sika
deer, roe deer and moose (Chen et al., 2007; Crawford et al., 2002;
Keel et al., 2003; Li et al., 2003b; Vikoren et al., 2006). Symptoms
in susceptible animals are most commonly reported to be chronic
weight loss, as well as mural folliculitis (mural pattern of
inflammation of the hair follicle), dermatitis, and alopecia (Crawford
et al., 2002). Upon histological examination the typical lesions
13

associated with the malignant catarrhal fever viruses are seen
(lymphoproliferation and generalized necrotizing vasculitis) (Chen
et al., 2007; Crawford et al., 2002).
Malignant Catarrhal Fever Affecting the White-Tailed Deer
Etiology
First described by Li and associates in 2000, malignant catarrhal
fever virus white-tailed deer variant (MCFV-WTD) was the third
virus attributed to the pathogenic group of gammaherpesviruses. It
was detected when deer exhibiting clinical signs of the MCF
syndrome as well as antibodies to a conserved epitope among
MCF viruses did not test positive for either OvHV-2 or AlHV-1 by
strain specific PCR. Degenerative primers specific to a conserved
region of the DNA polymerase gene were then utilized, and
amplification product occurred (Li et al., 2000). When this product
was analyzed, it was found genetically to exhibit 82% identity to
OvHV-2 and 71% identity to AlHV-1 (Kleiboeker et al., 2002; Li et
al., 2000). All animals reported to have been infected with this virus
were maintained in captive herds. The original reservoir host of this
virus is unknown, although it is estimated to be a close relative of
the sheep or goat (O'Toole and Li, 2008).
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Transmission of disease
Based upon reports, cases of MCF associated with white-tailed
deer occur in late fall or early winter, typically a time of high stress
(Kleiboeker et al., 2002; Li et al., 2000). The mode of transmission
of this virus is unknown, as the reservoir animal has not been
identified (Kleiboeker et al., 2002; Li et al., 2000; O'Toole and Li,
2008).
Pathology
In affected deer, MCFV-WTD causes the classic symptoms of MCF
syndrome described previously in cattle, with the exception of
corneal opacity (Li et al., 2000).

Treatment, Control and Prevention of Disease
Currently there is no reliable method to treat MCF syndrome in affected animals.
Occasionally supportive care with fluids and treatment with steroids and
antibiotics has been effective in helping animals recover, but this does not occur
consistently (Heuschele et al., 1985; Milne and Reid, 1990; Penny, 1998).
Whether treatment is actually effective in helping animals’ recovery is still not
proven, as treatment has not been shown to increase recovery in animals. There
are also many reports of animals recovering without treatment (Hamilton, 1990;
Kalunda et al., 1981; O'Toole et al., 1997).
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The best method for controlling the spread of disease in susceptible hosts such
as bison, deer, Bali cattle, water buffalo, and to a lesser extent, European breeds
of cattle, is to prevent exposure to known carrier animals: wildebeest, sheep and
goats. It has been suggested that waiting until later in the day to graze cattle in
wildebeest inhabited areas would greatly limit the exposure of cattle to AlHV-1,
as virus is inactivated rapidly in sunlight (Rossiter et al., 1983a). This would
allow wildebeest and cattle to share the best grazing land, and still limit the
amount of disease in cattle. There is no reliable way to produce virus-free
wildebeest calves, as some are infected transplacentally (Plowright et al., 1960),
and virtually all animals in a herd are infected by 4 months of age (Barnard et al.,
1989a; Mushi et al., 1980). A method to obtain virus-free sheep and goats has
been shown (Cooley et al., 2008; Li et al., 2005; Li et al., 1998; Muller-Doblies et
al., 2001). This consists of removing lambs from a positive flock by the age of
2.5 months. Kids were removed at 1 month and remained virus free. Derivation
of virus free animals from MCFV positive females has important implications for
disease control programs, especially in mixed species wildlife parks and
zoological gardens.
Attempts to develop a vaccine to prevent infections with AlHV-1, have been
made in the past without success (Plowright et al., 1975) . Currently the only
method of prevention available is proper management of susceptible species.
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Impact of Malignant Catarrhal Fever Viruses
There is a large variation in the impact that MCFV’s have, depending on strain of
virus and type of animal infected. Economic impact in Africa has been estimated
to cause losses of up to 5-10% in domestic cattle herds (Barnard et al., 1989b;
Bedelian, 2007; Plowright et al., 1975). In areas adjacent to wildebeest calving
zones, Massai pastoralists believe MCF to be the most important disease with
the largest impact on domestic cattle production, and in other areas where
wildebeest were less prominent, it remained the fourth most common disease.
Percent drop in sale price per animal infected with MCF in Africa was estimated
at 50% in 2003-2004 (Bedelian, 2007). Several exotic species are also
susceptible to AlHV-1, and losses in zoological gardens as well as in free-ranging
African wildlife have been reported (Castro et al., 1984; Hamblin and Hedger,
1984; Hatkin, 1980).
Although economic losses related to sheep associated MCF have not been
estimated, extremely high mortality rates have been reported in many herds of
animals, especially deer and bison (Blood et al., 1961; Brown and Bloss, 1992;
Clark et al., 1970; Hamilton, 1990; Li et al., 1999; Murray and Blood, 1961;
O'Toole et al., 2002; Otter et al., 2002; Schultheiss et al., 2000; Tomkins et al.,
1997). There have also been many reports of disease in free-ranging animals
(Neimanis et al., 2009; Schultheiss et al., 2007; Vikoren et al., 2006). It is difficult
to estimate the true losses of wildlife animals to sheep-associated MCF, as all
cases are not recovered.
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Losses in farmed and free-ranging cervids due to CpHV-2 have been reported
and have been substantial in some cases (Chen et al., 2007; Vikoren et al.,
2006). The symptoms of infection with CpHV-2 are not immediately detected
(generally chronic weight loss and alopecia), thus the true impact of this disease
may not be apparent, as it is most likely underreported.
To date, MCF associated with white-tailed deer has only been reported in captive
white-tailed deer, and losses were varied in the two reports (Kleiboeker et al.,
2002; Li et al., 2000). After discovery of this virus in captive white-tailed deer in
Missouri, a further survey of several deer samples from both captive and wild
white-tailed deer did not reveal MCFV-WTD infection and presence of the virus is
not considered to be widespread in Missouri (Kleiboeker et al., 2002). A 2005
survey of samples from hunter harvested free-ranging white-tailed deer in east
Tennessee revealed a rate of infection greater than 30%, with assumed
subclinical infection (unpublished data). The impact of infection with MCFV-WTD
in wild white-tailed deer is not yet understood.

Diagnostic Measures for MCF
Virus isolation
AlHV-1
Plowright and associates first isolated AlHV-1 in cell culture
((Plowright et al., 1960). He was later able to obtain cell-free virus
of an isolate (WC11) after 49 calf kidney transfers and a further 5 or
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10 passages as cell-free fluids in calf-thyroid cells (Plowright, 1968).
After passage, it was still able to cause fatal MCF in cattle with a
dose of 104 TCID50. This isolate is still utilized today for diagnostics,
and was essential in determining virus characteristics. Virus
isolation is not very specific, as other viruses may grow in cell
culture if the animal has a co-infection. Sensitivity can also be low,
as sample type and proper management are crucial for maintaining
live virus until it can be cultured (Mushi et al., 1980).
OvHV-2
Lymphoblastoid cells infected with OvHV-2 have been propagated
from cattle, deer and rabbits with sheep-associated malignant
catarrhal fever (Reid et al., 1989; Reid et al., 1983; Schuller et al.,
1990), but cell-free virus has not yet been cultivated.
Virus Neutralization Assay
This assay was developed by Plowright in 1967, utilizing the WC11 virus
isolate mentioned previously (Plowright, 1967). The virus neutralization
assay in use today still employs the AlHV-1 virus as the target of
neutralization, as cell free virus has never been isolated from other strains.
This assay works best for antibody against the alcelaphine group of
herpesviruses, and is used primarily in studying the range and extent of
natural gammaherpesvirus infections in wildlife, zoological gardens and,
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occasionally sheep populations. The virus neutralization assay is not used
as a diagnostic test in clinically affected animals, as these animals are not
able to produce virus neutralizing antibody (OIE, 2008). Animals with
sheep-associated MCF do not produce virus neutralizing antibodies to
AlHV-1 (Rossiter, 1983).
Serology
Indirect Immunoflorescence assay (IFA)
Although the IFA is not as specific as the virus neutralization assay,
it is useful in detecting antibodies to several varieties of ‘early’ and
‘late’ antigens in AIHV-1-infected cell monolayers. These are
antibodies that develop during the incubation period as well as
during the clinical course of the disease. This test is not very
specific, as other herpesviruses such as bovine herpesvirus-4 and
infectious bovine rhinotracheitis virus cross-react (Rossiter et al.,
1977). This assay can be utilized to detect sheep-associated MCF
when this disease is suspected, but should be used in concert with
another diagnostic method (OIE, 2008).
Enzyme-Linked Immunosorbent Assay (ELISA)
Many ELISA assays have been developed to detect antibody to
MCFV’s (Fraser et al., 2006; Frolich et al., 1998; Wan et al., 1988).
The most commonly accepted method of detecting antibody to
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MCFV infection is the competitive inhibition ELISA (OIE, 2008).
Developed in 1994, this assay was designed to detect antibody to
OvHV-2 using a MAb (15-A) targeting an epitope on a complex of
glycoproteins that appears to be conserved among all MCF viruses.
The antibody was raised against the wildebeest strain of MCF from
a Minnesota isolate very similar to the WC11 strain (Hamdy, 1978;
Li et al., 1994). Antibody to four MCFV’s has been detected: AlHV1,OvHV-2, CpHV-2 and MCFV-WTD, as well as one other very
similar gammaherpesvirus: AlHV-2 (Li et al., 1994). Originally an
indirect CI-ELIZA which utilized enzyme labeled anti-mouse
immunoglobuins for antibody detection, this test was reformatted as
a direct CI-ELISA in 2001 to increase sensitivity (Li et al., 2001c).
The MAb 15A was conjugated directly with an enzyme label and a
method was developed to precoat and store antigen-containing
plates at 4degrees C for long periods without degradation. After
modification, the sensitivity of this assay in cattle with clinical
sheep-associated MCF approximates 95%, (80% in bison). The
specificity was also increased, and is estimated to be 94% when
utilized with cattle, deer, and bison. According to the OIE, the CIELISA has the advantage of being faster and more efficient than
the IFA (OIE, 2008). In general the CI-ELISA method is frequently
shown to be more sensitive than the IFA in detection of herpesviral
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DNA (Nielsen and Vestergaard, 1996). Although this assay
appears to be highly sensitive in most clinically affected animals, it
has not been validated for use in detecting latent infection in nondiseased animals.
PCR
Nested Degenerative Herpesvirus PCR
First developed in 1996, this assay allowed for detection of many
new gammaherpesviruses. Primary and secondary PCRs are
performed with degenerate PCR primers targeted to a highly
conserved region within the herpesviral DNA-directed DNA
polymerase gene, using a nested format. This assay allows for the
determination of partial herpesviral sequences for which no data
have previously been reported. This is a sensitive (as little as 10
copies of DNA polymerase template per 100ng of DNA is
detectable) and broadly applicable approach to the detection and
identification of previously characterized herpesviruses present in
human and animal tissues (VanDevanter et al., 1996). Adaptations
of this PCR have been used to characterize new
gammaherpesviruses in the MCF family (Kleiboeker et al., 2002; Li
et al., 2000). The disadvantage of utilizing this assay for
diagnostics is that it is quite time-consumptive, as well as
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expensive to run. As the assay is not strain specific, product needs
to be sequenced in order to correctly identify strains, which requires
cloning and/or further processing. Also, several concentrations of
DNA, as well as variations in the amount of enzymes and
chemicals used must be evaluated in order to detect all virus
positive samples, as the addition of reagents such as dimethyl
sulfoxide (DMSO) has been shown to increase relative sensitivity in
detection of some viruses, but decrease relative sensitivity of
detection of others.
Strain specific PCR
Once a virus has been identified and genes have been
characterized, strain specific assays have been developed for use
in virus identification. These include traditional PCR assays (Baxter
et al., 1993; Crawford et al., 1999; Li et al., 2001a; Li et al., 1995;
Murphy et al., 1994; Wiyono et al., 1994), as well as real-time PCR
assays (Cunha et al., 2009; Traul et al., 2007). The development of
real-time strain specific assays for the detection of viral antigen in
diseased animals has increased efficiency by increasing specificity,
and has shortened the amount of time it takes to diagnose an
animal with infection. Most recently a real-time PCR assay was
developed to detect and differentiate malignant catarrhal fever
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viruses in clinical samples (Cunha et al., 2009). In this assay, one
pair of primers is utilized with fluorescently labeled probes specific
for OvHV-2, CpHV-2, MCFV-WTD, MCFV-ibex, and AlHV-1 to
identify these pathogenic MCFVs in clinical samples. All probes in
this assay were able to detect as few as 50 copies of the specific
viral DNA per reaction. Considering all five MCFV together, the
multiplex real-time PCR assay has 97.2% sensitivity. When
samples positive for other herpesviruses were analyzed,
amplification did not occur, therefore this assay appears to be very
specific for the viruses it was developed to detect. This assay
should improve the length of time it takes to identify the strain of
MCFV generating disease in an animal, but has not been validated
for use in detecting latently infected animals.
A full description of the currently accepted diagnostic techniques for malignant
catarrhal fever viruses can be found in the OIE Manual of Diagnostic Tests and
Vaccines for Terrestrial Animals (OIE, 2008).

Malignant Catarrhal Fever viruses in Tennessee
Background information
The occurrence of malignant catarrhal fever in Tennessee ruminant
populations has not been investigated and quantified, but has been
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assumed to occur sporadically and to be most commonly associated with
exposure to infected sheep. In 2005, a bison was presented to the
University of Tennessee College of Veterinary Medicine necropsy service.
Based upon gross and histological examination, it was believed the animal
had succumbed to an infection of malignant catarrhal fever virus.
Diagnostics were performed by National Veterinary Services Laboratory
(NVSL) in Fort Collins, CO. Sheep-associated MCF was diagnosed by
presence of OvHV-2 DNA. The animal had not been exposed directly to
any sheep, and there were no sheep located within a 5 mile radius of the
farm. Two additional cases of malignant catarrhal fever virus disease in
local bison from intermingled livestock sources and 2 sheep-associated
MCF affected cattle with no known exposure or proximity with sheep were
then identified over the next six months.
The source of the infection in the bison and cattle was unknown, therefore
it was hypothesized that white-tailed deer in the area may have
transmitted the disease to the animals. Historically, deer have been
suspected of being able to transmit OvHV-2 to cattle and bison (Imai et al.,
2001), although this has yet to be proven. In the fall of 2005, an initial
limited- survey of deer harvested in the region was undertaken. The
cELISA was used to identify potentially infected deer, and DNA was
extracted from the sodium heparinized blood of antibody positive samples.
Based on the cELISA results there appeared to be widespread, moderate
25

rate (32 %: 30/92) of wild white-tailed deer in at least 12 counties in the
eastern and middle areas of Tennessee that possessed antibody to a
conserved epitope of the MCF family, but none of the animals were
positive for OvHV-2 DNA (unpublished data). When additional tests were
performed, it was determined that the antibody positive animals had been
infected with the malignant catarrhal fever virus white-tailed deer variant
(MCFV-WTD) (unpublished data).
Tennessee is second in the United States only to Texas in numbers of
meat goats produced, with over 100,000 animals (National Agriculture
Statistics Service, 2002). Due to the belief that CpHV-2 is endemic in
domestic goats with infection rates similar to that of OvHV-2 in sheep (Li
et al., 2005), as well as reports of serious disease in cervid species as a
result of infection with this virus, (Crawford et al., 2002; Keel et al., 2003;
Li et al., 2003b) we were prompted to investigate prevalence of CpHV-2 in
goats and deer in the state of Tennessee.
Project Objectives
Based upon the prior experimental data, clinical information obtained by
the necropsy and LACS services, and a review of the literature, we believe
MCF viruses are present in an interface of ruminant species across the
state of Tennessee. We have developed several objectives to investigate
the prevalence of MCFV’s in Tennessee ruminant populations.
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Objective 1: Determine the prevalence of MCFV’s in Tennessee deer
populations
Objective 2: Determine the presence and prevalence of CpHV-2 in
Tennessee goat herds
Objective 3: Determine if cattle have been infected with OvHV-2 and/or
other MCFV’s and if the prevalence of virus is higher in dead/debilitated
animals than in healthy herd animals
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Chapter 2. Malignant Catarrhal Fever virus-White Tailed Deer
variant in Tennessee Wild and Domestic Cervid Populations
Abstract
For decades, malignant catarrhal fever viruses (MCFV’s) have been reported to
cause disease in cervids. Prevalence of MCFV’s in Tennessee deer populations
has not been investigated previously, so blood and/or lymph node samples were
obtained from wild white-tailed deer harvested in the 2006, 2007, and 2008
Tennessee hunting seasons, as well from captive deer at local mixed species
animal parks. Strain specific real-time polymerase chain reaction was performed
to determine prevalence of infection with ovine herpesvirus-2, caprine
herpesvirus-2, and malignant catarrhal fever virus white-tailed deer variant in
individuals without apparent disease. Overall, prevalence of MCFV’s in
Tennessee cervids was less than 3%. MCFV’s do not appear to be an issue of
major concern for the health of Tennessee cervid populations, although these
viruses are present in the deer population, and should be considered a health
risk.

Introduction
Malignant catarrhal fever viruses have been reported to cause disease in several
cervid species, and in farmed deer have been known to cause severe economic
losses due to mortality (Brown and Bloss, 1992; Crawford et al., 2002; Heuschele
et al., 1985; Imai et al., 2001; Keel et al., 2003; Kleiboeker et al., 2002; Klieforth
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et al., 2002; Li et al., 2000; Li et al., 2003b; Reid, 1991; Reid et al., 1987; Reid et
al., 1989; Schultheiss et al., 2007; Tomkins et al., 1997; Wilson et al., 1983).
There have also been many reports of disease associated with OvHV-2 and
CpHV-2 in free-ranging animals (Neimanis et al., 2009; Schultheiss et al., 2007;
Vikoren et al., 2006). The population of free-ranging white-tailed deer in the state
of Tennessee is estimated to exceed 900,000 animals. This species is
considered to be the most important big game mammal of the eastern U.S., and
hunting related expenditures associated with white-tailed deer hunting have an
economic impact exceeding $650,000,000 annually in Tennessee (TWRA, 2010).
Clinical signs of MCF vary depending on the strain of virus the animal is infected
with. In deer, sheep-associated MCF appears to be peracute or acute, and
animals are reported to succumb within 12 hours of onset of elevated
temperature, mild diarrhea and inappetance, without developing the
characteristic signs of the disease (Reid, 1991), although some deer have
developed acute hemorrhagic enteritis followed rapidly by death (Wilson et al.,
1983). It is difficult to estimate the true losses of wildlife to sheep-associated
MCF, as few cases are recovered.
Losses in farmed and free-ranging cervids due to CpHV-2 have been reported
and in some cases were substantial (Chen et al., 2007; Vikoren et al., 2006).
The symptoms of infection with CpHV-2 are not easily detected (generally
chronic weight loss and alopecia), thus the true impact of this disease may not be
apparent, as it is most likely underreported. Tennessee is second in the United
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States only to Texas in numbers of meat goats produced, with over 100,000
animals (National Agriculture Statistics Service, 2002). Due to the belief that
CpHV-2 is endemic in domestic goats with infection rates similar to that of rates
of OvHV-2 in sheep (Li et al., 2005), as well as reports of serious disease in
cervid species as a result of infection with this virus (Crawford et al., 2002; Keel
et al., 2003; Li et al., 2003b), we were prompted to investigate prevalence of
infection with CpHV-2 in deer in the state of Tennessee.
First described by Li and associates in 2000, MCFV-WTD was the third virus
attributed to the pathogenic group of gammaherpesviruses. The original
reservoir host of this virus is unknown, although it is estimated to be a close
relative of the sheep or goat (O'Toole and Li, 2008). Cases of MCF associated
with white-tailed deer occur in late fall or early winter, typically a time of high
stress (Kleiboeker et al., 2002; Li et al., 2000). MCFV-WTD causes most of the
classic symptoms of MCF syndrome described previously in cattle, (i. e., serous
ocular discharge, anorexia, depression, conjunctivitis, and periocular and nasal
epithelial erosions, although not corneal opacity) in white-tailed deer (Li et al.,
2000; O'Toole and Li, 2008).
To date, MCF associated with white-tailed deer has only been reported in whitetailed deer, and losses varied in the two reports (5 of 6 deer in one study, 1 deer
each from 3 separate farms in another, where no other animals at the farms were
affected)(Kleiboeker et al., 2002; Li et al., 2000). A 2005 preliminary survey of
samples from wild white-tailed deer in east Tennessee revealed a rate of
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infection with MCFV-WTD greater than 30%, with assumed subclinical infection
(Robert Donnell, personal communication). The impact of infection with MCFVWTD in wild white-tailed deer is not yet understood, and in Tennessee has not
been extensively investigated. The objective of this study was to determine the
prevalence of MCFV’s in Tennessee cervid populations, primarily white-tailed
deer. Although the most common method utilized to estimate prevalence of
MCFV exposure in free-ranging wildlife has been the competitive inhibition
enzyme linked immunosorbance assay (Frolich et al., 1998; Li et al., 1996;
Zarnke et al., 2002), strain-specific real-time PCR was utilized in this study for
detection of MCFV DNA. Real-time PCR was utilized because it can be
developed to detect specific strains of MCFV, and is less time and resource
consumptive than traditional PCR and degenerative herpesviral consensus
primer PCR methods. Blood and lymph node samples were obtained from whitetailed deer harvested in the 2006-2008 hunting seasons, as well as from cervids
in local mixed species animal parks.

Methods
Sample Collection
Samples were collected primarily at Tennessee Wildlife Resource Agency
approved check-in stations during the 2006, 2007, and 2008 white-tailed
deer hunting seasons (Table 2.1). The permitted harvest of antlerless
deer (deer with no antlers, or those with antlers less than 3 inches in
31

length) varied per county (in some counties as little as 5 per season, in
others as many as 3 per day). For bucks (any deer with at least one antler
longer than 3 inches) the statewide limit allowed is 3 per season. All
animals harvested must be >6 months of age. In addition to check-in
stations, wild-game processors were utilized to collect samples from
hunter-harvested deer, and sampling packets were distributed to hunters.
Blood and/or lymph nodes were obtained from every animal where
possible. The primary lymph node extracted was the inguinal lymph node,
due to ease of access and decreased chance of meat contamination at
this location. Pooled blood was removed from the body cavity of field
dressed animals when available. Animals were considered to be in good
health if they exhibited good body condition at the time of sampling.
A small number of blood samples were obtained in 2008 from cervid
species at two local mixed species parks. Both parks contained several
species of deer, goat and sheep, as well bison and exotic species
(aoudad, zebra, ostrich, emu, etc). Where live animals were utilized to
obtain samples, animals were handled in a manner approved by the
University of Tennessee Institute of Animal Use and Care committee.
Locations of the sampled deer were categorized by Tennessee Wildlife
Resource Agency Region (1-4) (Figure 2.1). All blood samples were
stored in vacutainer tubes containing heparin at 4 degrees C until further
processing. Lymph nodes were collected, placed in sterile plastic conical
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tubes, and stored at -20 degrees C until further processing. When
necessary, some lymph node samples were stored in 10% buffered
neutral formalin until further processing, as these samples were obtained
from either hunter sampling packets or areas a considerable distance from
the university (primarily Region 1 samples), and length of transit would
have led to degradation of the sample.
Table 2.1 Tennessee Wildlife Resource Agency Permanent Opening Dates for
Deer Hunting
Samples were collected at TWRA checking stations in November and December, but samples were
collected at wild-game processing facilities throughout the hunting seasons (2006-2008). Sample
collection ended each year by December 24. Information obtained from the Tennessee Hunting and
Trapping Guide (TWRA, 2009).

Hunting Type

Opening Date

Deer/Archery

Fourth Saturday in September

Deer/Muzzleloader

First Saturday in November

Deer/Gun

Saturday before Thanksgiving

Deer/Young Sportsman

Last Saturday in October
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Figure 2.1 Tennessee Wildlife Resource Agency Region Map

Molecular analysis
Sample preparation
DNA was extracted from blood and/or tissue using the DNeasy
blood and tissue kit according to the provided manufacture’s
protocol (Qiagen, Valencia, CA).
OvHV-2 and CpHV-2
Real-time PCR was performed according to the following protocol:
per each reaction: 2 microliters extracted DNA, 10 microliters
Taqman Universal PCR master Mix (Applied Biosystems, Foster
City, CA) 0.4 microliters Rox Reference Dye II (Madison, WI), 0.9
microliters each of forward and reverse primer, 0.25 microliter
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Probe, and 7.55 microliters DNase RNase free water. The reaction
protocol is as follows: 50 degrees C for 30 seconds, 90 degrees C
for 10 minutes, then 42 cycles of: 95 degrees C for 15 seconds,
OvHV-2:61 degrees C for 1 minute /CpHV-2: 50 degrees C for 1
minute, and 72 degrees C for 30 seconds. Samples were
considered positive if amplification occurred above the baseline
prior to cycle 40.
OvHV-2 Primer and Probe set: F primer sequence: 5’- TGG TAG
GAG CAG GCT ACC GT-3’ R primer sequence: 5’-ATC ATG CTG
ACC CCT TGC AG-3’ Probe (P: 5’- 56-FAM/TCC ACG CCG TCC
GCA TAA GA/3BHQ_1-3’) (IDT, Coralville, PA),
CpHV-2 Primer and Probe set: F primer sequence: 5’- CAC TAC
AAC ATC CTG TCC TT-3’ R primer sequence: 5’- AGG GTA AAG
AAT GCA TAC AG -3’ Probe: 5’- 56-FAM/ AGA CGA AGA CAT
AAT TAT CCA GAT ATC /3BHQ_1-3’ (IDT, Coralville, PA).
OvHV-2 and CpHV-2 primer and probe sets were developed
previously in the lab for use with another real-time PCR apparatus
(personal communication). Temperatures were adjusted to
accommodate the StepOne® unit from Applied Biosystems.
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MCFV-WTD
To develop an assay mix to identify MCFV-WTD in cervids, the
program File Builder v 3.1 was utilized (Applied Biosystems). The
MCFV-WTD DNA polymerase gene (partial cds) sequence
obtained in GenBank, accession number: AF387516 was imported,
and a section not found in OvHV-2, AlHV-1 or CpHV-2 was
designated for use within the probe. Areas within the sequence (>
12 base pairs) similar to human, mouse, bovine, and ovine DNA
were eliminated from the segment. This segment was then
submitted to Applied Biosystems for final primer and probe design.
The StepOne® unit from Applied Biosystems was utilized for realtime PCR.
Real-time PCR was performed according to the following protocol:
per each reaction: 2 microliters extracted DNA, 10 microliters
Taqman Universal PCR master Mix (Applied Biosystems, Foster
City, CA) 1 microliter of custom Taqman gene expression assay
mix (Forward primer sequence: 5’- AGC AAA TAT GCC CAA CCC
AGA TTA T-3’; Reverse primer sequence: 5’- GAG GCT AGC TTG
TCG CTG AA-3’; Probe: 5’- 56-FAM/ AAT CGC CCC ACA CTA
AC/3BHQ_1-3’) (Applied Biosystems, Foster, CA), and 7 microliters
DNase RNase free water. The reaction protocol is as follows: 50
degrees C for 2 minutes, 90 degrees C for 10 minutes, then 40
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cycles of: 95 degrees C for 15 seconds, 60 degrees C for 1 minute.
As this was a new assay, samples from a sheep infected with
OvHV-2 and a deer infected with CpHV-2 (provided by Hong Li of
the USDA-ARS) were utilized to confirm specificity. In addition,
plasmid DNA containing a portion of the MCFV-WTD DNA
polymerase gene obtained from Stephen Kleiboecher (formerly of
the University of Missouri), as well as DNA from a deer that had
died from MCFV-WTD (provided by Hong Li of the USDA-ARS)
were utilized as positive controls. Finally, samples exhibiting
amplification above the baseline prior to cycle 40 were rerun in
duplicate and these products were sequenced at the University of
Tennessee Molecular Biology Resource Facility to confirm
presence of MCFV-WTD DNA.

Results
Sample Collection
Blood and lymph node samples were collected from check-in stations,
farms, and processing facilities throughout the 4 TWRA regions. A list of
assayed samples per region is given in Table 2.2.
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MCFV-WTD Assay Development and Prevalence
The assay mix and protocol provided by Applied Biosystems worked well
to detect MCFV-WTD DNA polymerase gene DNA. Both samples utilized
as positive controls were detected by the assay. The relative sensitivity of
the assay (based upon serial dilutions of a known copy number of the
MCFV-WTD plasmid DNA positive control) showed that the probe was
able to detect as few as 4 copies of viral DNA per reaction (data not
shown). Also, the probe was highly specific, with no cross-reactivity
detected with OvHV-2 or CpHV-2 positive samples.
Overall, prevalence of MCFV-WTD DNA was greater than any other
MCFV in Tennessee cervids, at 2.9% (23/784), although this was much
lower than preliminary data from the 2005 season (30 %). The highest
prevalence (3.9%) was found in Region 4 (which was the region utilized
for sample collection in the preliminary 2005 study. The lowest
prevalence of MCFV-WTD (0.6%) was found in Region 1 (Table 2.3). All
but one of the 23 positive samples were obtained from deer in the 2006
hunting season.
OvHV-2 Prevalence
Prevalence of OvHV-2 DNA in samples was quite low (0.1%), with only
one deer testing positive of 781 sampled and tested. The only region with
a positive sample was Region 3 (Table 2.3).
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CpHV-2 Prevalence
There was no CpHV-2 DNA detected in any of 724 animals sampled and
tested (Table 2.3).
Table 2.2 Samples Taken per TWRA Region and Assay Performed
Blood and/or lymph node samples were obtained from Tennessee cervids from 2006-2008, primarily
during the Tennessee deer hunting seasons. Samples are from white-tailed unless otherwise indicated.

Region

Assay

Blood and Lymph
Node

Blood Only

Lymph Node
Only

Total Animals
Tested

1

MCFV-WTD

69

30

56

155

OvHV-2

87

18

68

173

CpHV-2

67

38

62

167

MCFV-WTD

17

19

80

116

OvHV-2

16

19

73

108

CpHV-2

9

3

59

71

MCFV-WTD

38

48

93

179

OvHV-2

40

42

96

178

CpHV-2

30

48

90

168

MCFV-WTD

169

20*

145

334

OvHV-2

162

12#

148

322

CpHV-2

101

14*

203

318

2

3

4

* includes 4 sika deer, 2 Elk, and 1 Axis deer
# includes 1 Axis deer

39

Table 2.3 Prevalence of MCFV per TWRA region
Strain Specific real-time polymerase chain reaction was performed on samples obtained primarily in the
2006, 2007, and 2008 Deer hunting seasons.

1

MCFV-WTD
Pos/Tested (%)
1/155 (0.6)

MCFV DNA Present
OvHV-2
Pos/Tested (%)
0/173

CpHv-2
Pos/Tested (%)
0/167

2

4/116 (3.5)

0/108

0/71

3
4

5/179 (2.8)
13/334 (3.9)

1/178 (0.6)
0/322

0/168
0/318

Total

23/784 (2.9)

1/781 (0.1)

0/724

Region

Discussion
Data from this study strongly suggests that MCFV’s are being maintained as
subclinical infection in Tennessee cervid populations. This is believed to be the
first report of MCFV-WTD and OvHV-2 infection in white-tailed deer without
clinical disease, as all previous reports were of deer that had died of apparent
MCF disease (Kleiboeker et al., 2002; Li et al., 2000; Vikoren et al., 2006).
MCFV-WTD and OvHV-2 are believe to be highly virulent in deer, therefore
reports of infection in deer not related to disease are valuable in understanding
the nature of MCF viruses in deer. Although MCFV’s have typically been
characterized as highly virulent in cattle, these hosts have also been shown to be
susceptible to OvHV-2 infection without succumbing to disease (Taus et al.,
2006). Cattle are believed to be less susceptible to sheep-associated MCF than
to wildebeest associated MCF (Loken et al., 2009). Similar to cattle, deer may
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be less susceptible to disease caused by MCFV-WTD, as more deer were
detected with infection with this MCFV than any other strain in this study.
The difference of prevalence reported in 2005 preliminary data (~30%) compared
with this study could be related to several factors. Data from 2005 came
primarily from animals harvested in Eastern Tennessee. During the hunting
season of 2005, East Tennessee as well as the rest of the state experienced
significant drought (Figure 2.2). Drought could have led to higher stress in deer
populations, making them more susceptible to infection. Additionally, animals will
have more contact with each other during drought as they congregate at
common water and food sources, leading to increased transmission of
pathogens.
Another factor which may have influenced the prevalence (or lack thereof) of
MCFV-WTD infection in 2007 and 2008 hunting seasons may have been an
outbreak of epizootic hemorrhagic disease (EHD) prior to and during the 2007
hunting season (Figure 2.3) (Hodge, 2007). Infection with an MCFV could have
made deer less resistant to infection with EHD, leading to increased mortality of
MCFV infected deer and therefore a lower number of infected deer at the times
of the survey.
The presence of only one deer with OvHV-2 infection may be explained by
reports that in deer this virus causes disease which is peracute or acute, and
animals typically succumb to disease within 12 hours of infection.
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Figure 2.2 Departure From Normal Precipitation (inches) in East Tennessee
During the 2005 Tennessee Deer Hunting Season
(October 1, 2005 - December 31, 2005)
Tennessee is highlighted by a black box. This figure was adapted from the NOAA Southern Regional
Climate Center website
http://www.srcc.lsu.edu/maps/current/index.php?action=update_userdate&daterange=OND&year=05)
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Severe (>10% Mortality)
Moderate (5-10% Mortality)
Insignificant (<5% Mortality)
Figure 2.3 Severity of the 2007 EHD Outbreak in Tennessee Deer Populations
Figure taken from the 2009 Tennessee Hunting and Trapping Guide (TWRA, 2009)

The lack of CpHV-2 infection in Tennessee cervid populations, particularly in, the
largest area of goat production in the state (region 2) was surprising, as CpHV-2
has been reported to cause chronic disease in cervids (Li et al., 2003b; Vikoren
et al., 2006), and Tennessee is the second largest meat goat producing state in
the U.S. In a recent study (unpublished), prevalence of CpHV-2 in Tennessee
goat herds was much lower than that reported in other studies (7% compared to
73% of animals tested), which may explain the lack of CpHV-2 infection in
Tennessee cervids.
Studies to determine susceptibility of deer to MCFV-WTD are impeded due to the
lack of evidence supporting a specific carrier animal for MCFV-WTD. Without
knowledge of a carrier animal, virus cannot be obtained to utilize in experimental
infection studies, and naïve deer cannot be housed with a carrier animal to
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investigate natural transmission. Although goats are the known reservoir of
CpHV-2, studies have not been performed to determine susceptibility of deer to
this virus, and a method of isolating virus from goats for utilization in
experimental transmission has not been established.
Malignant catarrhal fever viruses are recognized to cause epizootics of high
mortality in farmed deer (Brown and Bloss, 1992; Reid, 1991; Tomkins et al.,
1997), but more information needs to be obtained to determine if infection in freeranging cervids has as large an impact on the cervid population. With an
estimated population of 900,000 free-ranging deer in the state of Tennessee, an
MCFV-WTD prevalence of 3% indicates that an estimated 27,000 deer may be
latently infected with this virus.
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Chapter 3. Caprine-Herpesvirus-2 Prevalence and Shedding
Patterns in Tennessee Goat Herds
Abstract
Virtually all domestic sheep are believed to become infected with OvHV-2. The
carrier status of CpHV-2 in goats has been estimated to be similar to that of
OvHV-2 in sheep. Research was needed to confirm that CpHV-2 infection in
goats is similar. In the summer of 2008, 3-5 mls of whole blood were taken from
goats at nine Middle and East Tennessee goat farms selected based upon
convenience of location. Samples were analyzed for presence of caprine
herpesvirus-2 DNA to estimate prevalence of this virus in Tennessee goat
populations. To investigate infection patterns, goats from a local petting zoo
were routinely sampled every 2-3 weeks over a period of 3 months. Of the nine
farms sampled, 3 had animals which tested positive to CpHV-2 DNA, with
prevalence ranging from 7 to 17 percent. Three of 15 petting zoo goats were
shown to intermittently exhibit presence of viral DNA in blood samples obtained
over the period of the study. It appears that in general, prevalence of CpHV-2 in
goats is lower than OvHV-2 in sheep, but recrudescence of viral infection of
CpHV-2 in goats and OvHV-2 in sheep is similar.

Introduction
Goats have been suggested to be a source of malignant catarrhal fever virus
where sheep and wildebeest were not present, but the agent of infection was
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believed to be OvHV-2 (Li et al., 1996; Wiyono et al., 1994). In 2001, a novel
gammaherpesvirus in goats causing disease in cervid species was discovered
and designated caprine herpesvirus-2 (CpHV-2) (Chmielewicz et al., 2001; Li et
al., 2001b). Similar to ovine herpesvirus-2 (OvHV-2) in sheep and alcelaphine
herpesvirus-1 (AlHV-1) in wildebeest, the goat appears to be the carrier animal
and infection with CpHV-2 does not cause recognized disease in goats.
The infection and transmission pattern of this virus in goats has been estimated
to be similar to that of OvHV-2 in sheep; virtually all animals are believed to be
infected, and the young are not infected transplacentally, but are believed to be
infected after 2 months of age. In a previous study, prevalence of CpHV-2
infection in goats sampled from multiple herds in several states was shown to be
73 percent by PCR (Li et al., 2001b). ( In this report, prevalence of CpHV-2 DNA
was reported in 84% of seropositive animals, the value of 73% was obtained by
dividing the total number of positive animals (n=104) by the total number of
animals sampled, regardless of antibody status (n=142).
Similar to OvHV-2 infection in sheep, when kids are separated from the herd at
one week of age, they do not become infected with CpHV-2 virus (Li et al., 2005).
Also, adult goats are susceptible to CpHV-2 when co-mingled with infected
animals (Li et al., 2005). Goats have been shown to be co-infected with CpHV-2
as well as OvHV-2 (Li et al., 2001b; Li et al., 2005), but to date there have not
been studies to show co-infection with these viruses in sheep.
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Tennessee is the second highest producing state of meat goats in the United
States (National Agriculture Statistics Service, 2002). Although these animals
are raised for meat purposes, does can be kept for many years for breeding
purposes, therefore if infection with CpHV-2 is occurring in goat herds, it is
believed the virus will persist on the farm. To date there have been no surveys
performed to determine CpHV-2 prevalence that have included goat herds in any
of the southeastern states. Therefore this study was performed with the objective
of investigating prevalence of CpHV-2 infection in Tennessee goat herds to
determine if it is equivalent to that reported in goats in other states. In addition to
this, a second objective was to investigate the pattern of latent infection and
circulation of viral DNA in the goats’ bloodstream, as little is known regarding
infection patterns in goats. To determine the pattern of infection and latency of
CpHV-2 in goats, animals in a local petting zoo were sampled over a period of 3
months to determine how often adult animals (>1 year of age) exhibited
circulating viral DNA in the bloodstream when infected with CpHV-2. Presence
of circulating viral DNA in the blood was used as an indication of the animal’s
ability to shed virus to other animals.

Methods
Animals and Sample Collection: Prevalence
Nine goat producing farms were selected based upon convenience of
location (primarily East Tennessee, and one Middle TN farm) and owner
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willingness to participate in research studies at the University of
Tennessee. These farms included various breeds of domestic goats
ranging in age, number and breed. In the summer of 2008, 3-5mls of
whole blood was collected from each goat at the farms (with the exception
of farm D, where a portion of animals (n=150) selected by the farm
manager were sampled, as there were over 400 goats on the farm) under
a protocol approved by the University of Tennessee Institutional Animal
Care and Use Committee (IACUC). This blood was stored in vacutainer
tubes containing sodium heparin (BD Medical, Franklin Lakes, NJ) at 4
degrees C until further processed.
Animals and Sample Collection: Infection Patterns
A group of animals from a local petting zoo including Nigerian Dwarf
(n=15: 13 adults and 2 kids) and Oberhasli goats (n=2), as well as Tunis
sheep (n=2) were sampled every 2-3 weeks for just over 3 months during
the summer of 2008 (April 30-August 15). The kids were added to the
sampling protocol as they were born. Whole blood, 3-5 mls., was
collected from each animal under a protocol approved by the University of
Tennessee IACUC. This blood was stored in vacutainer tubes containing
sodium heparin (BD Medical, Franklin Lakes, NJ) at 4 degrees C until
further processed.
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Sample Processing and Molecular Analysis
DNA was extracted using the DNeasy blood and tissue kit according to the
provided manufacture’s protocol (Qiagen, Valencia, CA). Real-time PCR
was performed according to the following protocol: per each reaction: 2
microliters extracted DNA, 10 microliters Taqman Universal PCR master
Mix (Applied Biosystems, Foster City, CA) 0.4 microliters Rox Reference
Dye II (Madison, WI), 0.9 microliters each of Forward and Reverse primer
(F primer sequence: 5’- CAC TAC AAC ATC CTG TCC TT-3’ R primer
sequence: 5’- AGG GTA AAG AAT GCA TAC AG -3’) 0.25 microliters
Probe (P: 5’- 56-FAM/ AGA CGA AGA CAT AAT TAT CCA GAT ATC
/3BHQ_1-3’) (IDT, Coralville, IA), and 7.55 microliters DNase RNase free
water. The reaction protocol is as follows: 50 degrees C for 30 seconds,
90 degrees C for 10 minutes, then 42 cycles of: 95 degrees C for 15
seconds, 50 degrees C for 1 minute, and 72 degrees C for 30 seconds.
Samples were considered positive if amplification occurred above the
baseline prior to cycle 40. This assay targeted a conserved region of the
CpHV-2 DNA polymerase gene.
Statistical Analysis
A two-sample test of proportion was performed in STATA to compare
previously reported prevalence to prevalence obtained in this study to
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determine if there was a significant difference (p<0.05) between the
prevalence reported previously, and that reported in this study.

Results
Prevalence
A total of 373 goats of various breed and age from nine Tennessee farms
were sampled and tested by real-time PCR for presence of CpHV-2 DNA
(Table 3.1). All ages were included, although the majority of animals
sampled were believed to be >1 year (actual age of every animal sampled
was not known). Of the animals with known age, a few were only a few
weeks old, and others were as many as 12 years. Overall prevalence of
infection was 7% (26/373) (CI: 4-10%). Of the nine farms, only farms C,
F, and H had animals which tested positive for CpHV-2 DNA at the time of
sampling. Prevalence at these farms was 6.7%, 16.7% and 15.1%
respectively. Size of farm and breed of goat varied amongst the three
farms. Prevalence of CpHV-2 infection in goats was significantly lower
than the previously reported 73 percent (P<0.0001).
Infection and Recrudescence Patterns
Samples were taken from 13 adult goats and 2 adult sheep at the petting
zoo up to 8 times over the period of the study. Three of the 13 adult goats
were positive at different times over the period of the study, but were not
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consistently positive every time sampled (Table 3.2). One of the animals
that had tested positive gave birth to a kid within the study period. Both
kids born during the study period were negative for CpHV-2 DNA within
one week of birth, and remained negative through the end of the study (at
the end of the study both kids were less than 2 months old). Neither
sheep tested positive for CpHV-2 at any time.

Table 3.1 Prevalence of CpHV-2 in Domestic Goats from Middle and East
Tennessee
Blood samples were taken in the summer of 2008 from goats at Tennessee farms and molecular analysis
was performed to determine prevalence of CpHV-2 in Tennessee goat herds.
Farm Code

County

Breed(s)

Pos/Tested (%)

Date
collected

A

Knox

Saanen and Oberhasli

0/16

6/10/2008

B

Union

Nigerian Dwarf

0/14

6/19/2008

C

Franklin

Boer X and Nubian X

10/150(6.7)

7/22/2008

D

Knox

Oberhasli and Lamancha

0/12

6/19/2008

E*

Knox

Fainting and Pygmy

0/28

6/11/2008 and
7/23/2008

F

Cocke

Saanen, Guernsey, and
Nubian

8/48(16.7)

6/20/2008

G

Loudon

Pygmy

0/6

6/10/2008

H

Knox

Nubian X

8/53(15.1)

5/12/2008

I

Grainger

Nigerian Dwarf

0/46

7/25/2008

Total Collected

26/373(7)

*This farm also contained sheep, several cervid species, aoudads, and other exotic ruminants
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Table 3.2 Infection Patterns of CpHV-2 in a Petting Zoo
CpHV-2 specific real-time PCR amplification was performed on whole blood samples from animals in a
petting zoo containing goats infected with CpHV-2.
Animal ID
1

4/30/08
-

5/14/08
-

5/28/08
-

6/11/08
+

6/25/08
-

7/9/08
-

7/23/08
+

8/15/08
ND

2

-

-

-

-

-

-

-

ND

3

-

-

-

-

-

-

-

ND

4

+

-

+

-

-

-

+

ND

5

-

-

-

-

-

-

-

ND

6

-

-

-

-

-

-

-

ND

7*1

N/A

N/A

N/A

N/A

N/A

-

-

-

8

-

-

-

-

-

-

-

ND

9

+

-

-

-

-

-

+

ND

10

-

-

-

-

-

-

-

ND

11*2

N/A

N/A

N/A

N/A

N/A

N/A

-

-

12

-

-

-

-

-

-

-

ND

13

-

-

-

-

-

-

-

-

14

-

-

-

-

-

-

-

ND

15

-

-

-

-

-

-

-

ND

16*3

-

-

-

-

-

-

-

ND

17*3

-

-

-

-

-

-

-

ND

*1 Number 4’s kid
*2 Number 13’s kid
*3 Tunis sheep

N/A: animal was not present at this time of the study
ND: Sample was not taken

Discussion
Goats have been considered a source of MCF for many years, as they have
been known to be subclinically infected with OvHV-2, and hypothesized to be
able to spread that virus to other animals (Wiyono et al., 1994). In the past
decade, a novel gammaherpesvirus was discovered in goats and shown to cause
disease in several cervid species (Chen et al., 2007; Crawford et al., 2002; Keel
et al., 2003; Li et al., 2003b; Vikoren et al., 2006). Many similarities have been
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drawn between CpHV-2 in goats and OvHV-2 in sheep. Sheep are believed to
be ubiquitously infected with OvHV-2, and in a previous study, it appeared the
same was true for CPHV-2 in goats sampled from several different geographical
locations (Arizona, California, Florida, Minnesota, New York, Ohio, Oregon,
Washington and Alberta, Canada) and several breeds (Li et al., 2001b).
However, prevalence of CpHV-2 infection in goats included in the current study
(7 %) was significantly lower than the previously reported 73 percent. It is
unclear why there is such a dramatic divergence in prevalence between this
study and previous reports. Sensitivity of the assay previously reported was
reported to be 84%, but this number was obtained by dividing the number of PCR
positive animals by the number of seropositive animals, therefore the actual
sensitivity of this assay may be higher, as not all seropositive animals will have
circulating viral DNA. Seroprevalence of animals tested in this study was not
determined, therefore it was not possible to perform a sensitivity calculation
similar to that in the 2001 study. Relative sensitivity of the assay utilized in this
report (based upon serial dilutions of a known copy number of a reference
plasmid DNA) showed that the probe was able to detect as few as 13 copies of
CpHV-2 viral DNA per reaction (data not shown). Relative sensitivity of the assay
utilized in the 2001 study was not reported. Perhaps the detection of CpHV-2
DNA would have been increased by utilizing peripheral blood lymphocytes
instead of whole blood for DNA extraction, as MCFV’s are believed to circulate in
the lymphocytes of latently infected animals. Samples were frozen immediately
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after they were obtained which prevented collection of these cells for extraction.
It was not possible to perform DNA extraction immediately upon collection.
In this study, only herds with greater than 20 animals exhibited CpHV-2 infection.
Stress has been shown to be instrumental in virus recrudescence. It is possible
that herds with higher numbers of animals may be more stressed due to herd
dynamics and space limitations.

Animals tested at the petting zoo may have

shown infection and recrudescence due to the stress of being located at the
petting zoo, especially as traffic increases during the summer months, which was
the study period. Pregnancy did not appear to strongly induce viral
recrudescence, as only one of the two pregnant goats exhibited viral infection
over the course of the study, but further studies need to be performed to confirm
this. Neither kid born during the study had identifiable infection with CpHV-2,
consistent with earlier reports that kids do not obtain virus transplacentally (Li et
al., 2005). This is important information for virus control, as it is possible to
produce CpHV-2 free animals with proper management of the animals after birth.
Many mixed species parks co-mingle goats and susceptible cervid species (roe,
sika, moose, white-tailed deer, etc), and it is very important to be able to obtain
virus free goats to maintain good health in a mixed species environment. Further
sampling of additional Tennessee goat herds, as well as additional sampling of
animals in this study, may show higher prevalence of CpHV-2 overall, as adult
goats were shown to intermittently have recrudescence of virus. However, it

54

seems unlikely that prevalence would approach that previously reported, as it
was ten times lower in this study.
As goats have been shown to be co-infected with CpHV-2 and OvHV-2, another
aspect of this study was to see if sheep were also able to be infected with both
CpHV-2 and OvHV-2. The sheep as well as the goats at this petting zoo have
been sampled and tested routinely over the past several years for presence of
OvHV-2. Both sheep, as well as several of the adult goats, have shown previous
OvHV-2 infection (data not shown, OvHV-2 DNA presence was not assessed at
the time of this study). In this study, sheep did not exhibit infection with CpHV-2
at any time. It may be possible that due to infection with OvHV-2, sheep are
refractory or immune to infection with CpHV-2. Further studies need to be
performed with sheep not infected with OvHV-2 to see if they may be susceptible
to CpHV-2.
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Chapter 4. Malignant Catarrhal Fever Viruses in Cattle
Populations: A Comparison of Healthy and Non-MCF
Diseased Animals
Abstract
Malignant catarrhal fever is a lymphoproliferative disease that affects many
ruminant species. Disease in North American cattle is most commonly
associated with infection of OvHV-2, acquired by exposure to sheep. To date no
disease in cattle has been associated with MCF-WTD or CpHV-2. We
hypothesize that cattle may be infected with MCF viruses without succumbing to
disease, and this infection may recrudesce when the animal becomes ill or
debilitated due to complications other than MCF, contributing to the animal’s
morbidity. Blood samples from healthy or normal animals (n=156) were obtained
from five healthy cattle herds and one slaughter facility, as well as animals
(n=168) from 2 facilities which dispose of or screen dead and debilitated cattle to
investigate the prevalence of MCFV infection. Real-time PCR amplification
revealed MCF viral DNA was present in 31 percent of samples from dead or
debilitated cattle, in contrast to 1 percent of samples from healthy animals.

Introduction
Malignant catarrhal fever is a disease syndrome associated with a high fatality
rate in many ruminant species, most commonly cattle, deer and especially bison.
This disease is caused by a group of several gammaherpesviruses within the
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rhadinovirus subgroup. The strain of virus most commonly associated with
disease in ruminants outside of the African continent is ovine herpesvirus-2,
although both malignant catarrhal fever virus- white-tailed deer variant (MCFVWTD) and caprine herpesvirus-2 have been reported to cause disease in cervids
(Chen et al., 2007; Crawford et al., 2002; Keel et al., 2003; Kleiboeker et al.,
2002; Li et al., 2000; Li et al., 2001b; Li et al., 2003b; Vikoren et al., 2006).
Clinical signs vary depending on the species of animal infected, as well as the
strain of virus causing disease (O'Toole and Li, 2008).
In cattle, clinical signs of disease associated with OvHV-2 infection most
commonly include corneal opacity, persistent fever, enlarged lymph nodes,
mucosal ulceration, mucopurulent nasal and ocular discharge, diarrhea and
hematuria (Pierson et al., 1979). Sheep-associated MCF in cattle is most often
fatal, although several cases have been reported where cattle have survived
MCF following natural or experimental infection (Baxter et al., 1993; Hamilton,
1990; Milne and Reid, 1990; O'Toole et al., 1995; Otter et al., 2002). In other
instances, OvHV-2 infection can occur in cattle without concurrent development
of clinical MCF (Powers et al., 2005; Taus et al., 2006).
Two other rhadinoviruses within the MCF subgroup known to cause disease in
white-tailed deer and other cervid species, MCFV-WTD and CpHV-2, have not
yet been documented to cause disease in cattle.
Unlike alpha or beta herpes viruses, which seem to prefer lytic replication,
gammaherpesviruses seem to favor the initial establishment of latency (Fields et
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al., 2001). This could explain why many animals are able to become infected
with an MCFV without developing clinical disease. According to a 2005 report,
eight cattle from a dairy submitted for necropsy for reasons other than MCF had
various diseases, but upon PCR analysis of tissue, 2 of the animals were positive
for OvHV-2. This dairy had a history of sheep-associated MCF outbreaks, and
was located adjacent to a sheep feedlot. Several animals at the dairy were
positive for OvHV-2 without exhibiting any signs of clinical disease. It may be
possible that cattle develop a latent infection with a MCFV, and upon immunosuppression related to disease or injury, recrudescence of the virus occurs.
The purpose of this study is to investigate if diseased or immunocompromised
cattle exhibit a higher prevalence of infection with one or more of the gammaherpesviruses within the MCF group than do cattle in good health status. This
was done by collecting blood samples from healthy cattle on several farms, as
well as from two facilities that process dead or debilitated cattle for diagnosis
and/or disposal. Strain specific real-time PCR was performed to determine the
prevalence of MCFV infection, and a comparison of the prevalence of MCFV’s in
the two groups was performed to determine if there was a statistically significant
difference. This information may provide insight into the true nature of infection
with MCFV’s in cattle, as the prevalence of subclinical infection in cattle with
OvHV-2 has not been extensively investigated, and infection of cattle with CpHV2 and MCFV-WTD has not been reported.

58

Methods
Animals and Sample collection
Healthy animals
Six facilities were selected for this portion of the study based on
accessibility and owner or manager’s willingness to participate in a
research study. Five of the facilities selected were UT Research
and Education Centers (LD: dairy cattle, TN, FHB, AF and HR: beef
cattle) with herds maintained by the University of Tennessee. The
sixth facility was a private East Tennessee slaughter facility.
Samples were obtained from May 2006 to December 2007. At the
time of sampling, no animals with known MCF disease were
identified within any of the herds. Blood samples (3-5 mls.) were
obtained from each animal under a protocol approved by the
University of Tennessee Institutional Animal Care and Use
Committee (IACUC). This blood was stored in vacutainer tubes
containing sodium heparin (BD Medical, Franklin Lakes, NJ) at 4
degrees C until further processed.
Dead/debilitated animals
Blood samples (3-5 mls.) from cattle submitted to the University of
Tennessee Necropsy service (UTN) or to a regional (East
Tennessee) contractor utilized by the USDA for bovine spongiform
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encephalopathy surveillance were obtained for use in this portion of
the study. Although lymph node, blood and brain samples were
obtained from all animals in this category, blood samples were
chosen for analysis to maintain consistency between the two
sample groups. Information regarding cause of death was not
obtained for the majority of samples taken. County of origin was
recorded and this information was utilized in sample selection.
Sample Processing
DNA was extracted using the DNeasy blood and tissue kit according to the
provided manufacture’s protocol (Qiagen, Valencia, CA). DNA was stored
at -20 degrees C for future use.
Molecular Analysis
Sample Selection
Due to the large number of samples obtained during the course of
this study, systematic sampling methods were employed to select
samples for molecular analysis. Samples were chosen based upon
county location, and every third sample recorded for each county
was selected.
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MCFV-WTD
Real-time PCR was performed according to the following protocol:
per each reaction: 2 microliters extracted DNA, 10 microliters
Taqman Universal PCR master Mix (Applied Biosystems, Foster
City, CA) 1 microliter of custom Taqman gene expression assay
mix (Forward primer sequence: 5’- AGC AAA TAT GCC CAA CCC
AGA TTA T-3’; Reverse primer sequence: 5’- GAG GCT AGC TTG
TCG CTG AA-3’; Probe: 5’- 56-FAM/ AAT CGC CCC ACA CTA
AC/3BHQ_1-3’) (Applied Biosystems, Foster, CA), and 7 microliters
DNase RNase free water. The reaction protocol is as follows: 50
degrees C for 2 minutes, 90 degrees C for 10 minutes, then 40
cycles of: 95 degrees C for 15 seconds, 60 degrees C for 1 minute.
Samples were considered positive if amplification occurred above
the baseline prior to cycle 40. The target of this assay was a
conserved region of the MCFV-WTD DNA polymerase gene.
CpHV-2
Real-time PCR was performed according to the following protocol:
per each reaction: 2 microliters extracted DNA, 10 microliters
Taqman Universal PCR master Mix (Applied Biosystems, Foster
City, CA) 0.4 microliters Rox Reference Dye II (Madison, WI), 0.9
microliters each of Forward and Reverse primer (F primer
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sequence: 5’- CAC TAC AAC ATC CTG TCC TT-3’ R primer
sequence: 5’- AGG GTA AAG AAT GCA TAC AG -3’) 0.25
microliters Probe (P: 5’- 56-FAM/ AGA CGA AGA CAT AAT TAT
CCA GAT ATC /3BHQ_1-3’) (IDT, Coralville, PA), and 7.55
microliters DNase RNase free water. The reaction protocol is as
follows: 50 degrees C for 30 seconds, 90 degrees C for 10 minutes,
then 42 cycles of: 95 degrees C for 15 seconds, 50 degrees C for 1
minute, and 72 degrees C for 30 seconds. Samples were
considered positive if amplification occurred above the baseline
prior to cycle 40. The target of this assay was a conserved region
of the CpHV-2 DNA polymerase gene.
OvHV-2
Real-time PCR was performed according to the following protocol:
per each reaction: 2 microliters extracted DNA, 10 microliters
Taqman Universal PCR master Mix (Applied Biosystems, Foster
City, CA) 0.4 microliters Rox Reference Dye II (Madison, WI), 0.9
microliters each of Forward and Reverse primer (F primer
sequence: 5’- TGG TAG GAG CAG GCT ACC GT-3’ R primer
sequence: 5’-ATC ATG CTG ACC CCT TGC AG-3’) 0.25
microliters Probe (P: 5’- 56-FAM/TCC ACG CCG TCC GCA TAA
GA/3BHQ_1-3’) (IDT, Coralville, PA), and 7.55 microliters DNase
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RNase free water. The reaction protocol is as follows: 50 degrees
C for 30 seconds, 90 degrees C for 10 minutes, then 42 cycles of:
95 degrees C for 15 seconds, 61 degrees C for 1 minute, and 72
degrees C for 30 seconds. Samples were considered positive if
amplification occurred above the baseline prior to cycle 40. The
target of this assay was a non-functional tegument protein.
Statistical Analysis
A two-sample test of proportion was performed in STATA to compare
MCFV prevalence in healthy cattle samples to those from dead or
debilitated animals to determine if there was a significant difference
(p<0.05) between the two groups.

Results
A total of 156 samples from 5 counties: Marshall (n=93), Cumberland (n=33),
Greene (n=21), Union (n=7), and Robertson (n=2), were chosen for molecular
analysis from healthy animals, and 168 from 26 counties (Table 4.1) were
selected from dead/down cattle. The majority of dead/debilitated cattle samples
were obtained from 6 counties: Greene (n=50), Knox (n=22), Cocke (n=16),
Sevier (n=14), Washington (n=14) and Jefferson (n=10). MCFV DNA was
detected in 1 percent (CI: 0-3%) (n=2/156) of healthy cattle. In contrast MCFV
DNA was detected in 31 percent (CI: 30-44%) (n=52/168) of samples from
dead/debilitated cattle. Prevalence of MCFV DNA was significantly lower in
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healthy cattle (1%) than in dead/debilitated cattle (31%) (p<0.0001). Thirteen
percent (n=21/168) of dead/debilitated animals were positive for multiple
MCFV’s, and 2 (1%) of these were positive for all three strains. Individual
percentages for each group and virus, as well as overall are listed in Table 4.2.
The virus most prevalent in dead or debilitated animals was MCFV-WTD (27%),
followed by OvHV-2 (15%), then CpHV-2 (3%). The only viral DNA detected in
healthy animal samples was MCFV-WTD. No CpHV-2 or OvHV-2 DNA was
detected in animals in good health.

Table 4.1 Location by County of Samples Obtained From Dead/Debilitated
Animals
Every third sample obtained in each county was processed and utilized for detection of MCFV
prevalence. Samples came from University of Tennessee necropsy services, as well as a local facility
utilized by the USDA-APHIS for bovine spongiform encephalitis surveillance

Number of
County
Samples Analyzed
County
Anderson
1
Greene
Bledsoe
1
Hamblen
Blount
2
Hamilton
Carter
1
Hancock
Claiborne
4
Hawkins
Cocke
16
Jefferson
Cumberland
1
Knox
Fentress
1
Loudon
Grainger
4
Meigs
Total number of samples:

Number of
Samples Analyzed
50
3
1
1
8
10
22
3
1

County
Monroe
Roane
Scott
Sevier
Sullivan
Union
Washington
Williamson

Number of
Samples Analyzed
2
1
1
14
3
2
14
1
168
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Table 4.2 Prevalence of MCFV-WTD, CpHV-2, and/or OvHV-2 DNA in Healthy and
Dead/Debilitated Animals
Real-time PCR amplification was performed on samples from various facilities and percent infected
animals was reported based on health status.

Sample site
AF
ANA
FHB
HR
LD
TN

Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Total Healthy

BSE*1
UTN*2
Total
Dead/Debilitated
Total

Health Status

Dead/Debilitated
Dead/Debilitated

MCFV-WTD
Pos/tested (%)
0/21
0/7
0/5
0/2
2/93 (2)
0/28
2/156(1)

CpHV-2
Pos/tested (%)
0/21
0/7
0/5
0/2
0/93
0/28
0/156

OvHV-2
Pos/tested (%)
0/21
0/7
0/1
0/1
0/93
0/28
0/151

38/113 (34)
7/55 (13)

3/113(3)
2/55 (4)

22/113 (20)
3/55 (5)

45/166 (27)

5/168 (3)

25/165(15)

47/322 (15)

5/324 (1)

25/316 (8)

*1 Disposal and screening facility, samples from multiple farms in 14 counties
*2 University of Tennessee Necropsy service, samples from multiple farms in 22 counties

Due to the surprisingly high prevalence of MCFV-WTD DNA detected in this
study (27%), amplification product of a subset of samples (n=5) were sequenced
by the University of Tennessee Biology Resource Facility to confirm that crossreactivity was not occurring with any other bovine herpesvirus. All 5 assay
positive samples (4 from dead or debilitated cattle, as well as one from the
healthy cattle herd) exhibited 96-98% identity with the MCFV-WTD DNA
sequence reported previously (Kleiboeker et al., 2002; Li et al., 2000).
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Discussion
Infection of cattle with OvHV-2 has been shown to occur without development of
sheep-associated MCF syndrome (Powers et al., 2005; Taus et al., 2006). In
addition to infection without disease, recovery from sheep-associated MCF has
been reported, and cattle that have recovered from infection with OvHV-2 have
been demonstrated to remain positive by PCR for the virus for up to 24 months
(O'Toole et al., 1997). In a previous study, in healthy cattle herds that had
experienced an outbreak of sheep-associated MCF within the previous 5 years,
OvHV-2 DNA was present in blood samples from 4 percent (n=15 /360) of cattle
surveyed (Loken et al., 2009). Based upon this information, the 15 percent
prevalence of OvHV-2 DNA (n=25/165) in dead/debilitated cattle could be
explained by previous undiagnosed outbreaks in the herds from which these
animals were submitted. Unfortunately parameters under which the study was
set up did not allow identification/contact with the owners/herd managers of
positive cases.
This is the first report of infection of cattle with MCFV-WTD. In this study, 27%
prevalence of MCFV-WTD was recorded in dead/debilitated cattle. In a 2005
study performed in East Tennessee cervids, a similar prevalence (>30%) was
recorded in presumed healthy harvested deer, followed by a decreased
prevalence (3%) of MCFV-WTD in deer in 2006. It may be possible an outbreak
of this virus occurred in ruminants in the region in 2005, without development of
MCF symptoms. If cattle were infected with the virus, and did not become
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diseased, they may have maintained a latent infection for several months
following infection, similar to that reported with OvHV-2 infection, explaining
infection at the time of sampling. Another explanation for the high prevalence of
MCFV-WTD infection in dead/debilitated cattle is that viruses can recrudesce
when animals are undergoing periods of high stress (infection with another
pathogen, injury, overcrowding, heat stress, etc). If animals were infected in
previous years with an MCFV, recrudescence may have occurred prior to death.
This is also the first report of CpHV-2 infection in cattle. Prevalence of CpHV-2
infection in goat herds is lower in Tennessee (7%) than that reported in previous
studies of CpHV-2 in goats (73%)(Li et al., 2001b), which may explain why the
prevalence (3%, n=5/168) of this MCFV was not as high in the dead/debilitated
cattle as that reported for other strains.
Further studies need to be performed to determine the impact MCFV-WTD and
CpHV-2 may have on cattle populations and herd health. The carrier animal is
unknown for MCFV-WTD, therefore it is not possible to attempt natural
transmission of virus to cattle in a controlled setting. Natural transmission of
CpHV-2 to cattle from an infected goat has not been attempted. Also, there is no
known method of growing MCFV-WTD or CpHV-2 in vitro for use in experiment
infection studies, therefore studies of these viruses and their effect on cattle
populations are difficult to perform.
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Chapter 5. Discussion and Conclusions
Multiple Malignant catarrhal fever viruses are present in several species of ruminants
throughout the state of Tennessee. Occurrence of disease related to MCFV infection in
Tennessee is presumed to be similar to that in Europe and other American states. Its
incidence is sporadic and it is most commonly associated with exposure to infected
sheep. Disease related to infection with MCFV-WTD and CpHV-2 has not been
reported in Tennessee cattle or cervid populations.
This study demonstrated that healthy cattle and cervids can be infected with OvHV-2
and MCFV-WTD without apparent disease, and that dead or debilitated cattle were
infected with CpHV-2. The previously unreported discovery of infection in cattle with
CpHV-2 MCFV-WTD opens a new avenue of investigation into the pathology and
virulence of MCFV’s in domestic cattle. Perhaps infection of cattle with CpHV-2 or
MCFV-WTD causes a previously unrecognized pattern of disease in this species.
Based on the discovery of MCFV infection without concurrent signs of disease in cattle
and deer, fatality rates related to infection with an MCFV may be much lower than
previous estimates, especially in white-tailed deer (Brown and Bloss, 1992; Kleiboeker
et al., 2002; Li et al., 2000; Otter et al., 2002). The prevalence of MCFV infection in
dead or debilitated cattle was significantly higher than that in healthy cattle, which may
provide some additional insight into the pathology of infection in cattle. The findings of
co-infection of dead and debilitated cattle with multiple MCF viruses raises the
possibility of long-term sub-clinical infection as it seems unlikely that the cattle
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contracted the viruses simultaneously or from another single point source. It appears
likely that MCFV’s, like other herpes viruses, may recrudesce when cattle are in poor
health. While it is tempting to speculate, additional information is needed to determine if
infection with one or more of the MCFV viruses increases morbidity in cattle when
experiencing co-infection with another unrelated pathogen.
The prevalence of CpHV-2 in goats is much lower in Tennessee than has been reported
previously in other areas of the US (Li et al., 2001b). Perhaps the detection of CpHV-2
DNA would have been increased by utilizing peripheral blood lymphocytes instead of
whole blood for DNA extraction, as MCFV’s are believed to circulate in the lymphocytes
of latently infected animals. Blood samples were frozen immediately after they were
obtained which prevented collection of these cells for extraction. Due to time
constraints and limited personnel, it was not possible to perform DNA extraction
immediately upon collection.
Low prevalence of CpHV-2 in Tennessee goat populations likely explains why no
evidence of infection was found in any of the cervids tested, and the low prevalence of
CpHV-2 infection in dead or debilitated cattle compared to the rates of infection for
OvHV-2 and MCFV-WTD. Additionally, cattle may be less susceptible to infection with
CpHV-2 than other MCFV’s.
While roughly equivalent percentages of the goat and deer populations were infected
with CpHV-2 and MCFV-WTD respectively, and CpHV-2 infection was identified in a
bovine, it is interesting that a much higher percentage of dead and debilitated cattle had
evidence of MCFV-WTD than CpHV-2. Again, while it is tempting to speculate, more
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detailed studies regarding the interface of cattle and deer versus cattle and goats are
necessary to elucidate the reason for this divergence.
One of the underlying reasons for this study was to determine if deer were a source of
OvHV-2 infection in cattle. OvHV-2 was identified in Tennessee deer but at a low
prevalence. At the recognized level of infection within “healthy” animals it is difficult to
ascribe a meaningful role to deer as a source of infection in cattle unless infected deer
rapidly succumb and were not available for testing. Acquiring samples from diseased
wild deer with known naïve cattle contact presents incredible difficult challenge.
No vaccines are available for prevention of MCFV infection. The primary method to
control spread of disease is to prevent contact between carriers and clinically
susceptible species. Studies have shown that it is possible to obtain OvHV-2 free
lambs and CpHV-2 free kids if they are removed from infected herds in a timely matter
(prior to 3 months for lambs, prior to nursing for kids) (Li et al., 2005; Li et al., 1998).
There is no known method to control infection of MCFV-WTD, as the carrier animal of
this virus is unknown. Information is needed regarding the pathology of this virus in
free-ranging white-tailed deer as well as other ruminants to determine if MCFV-WTD
can impact the health of ruminants other than captive white-tailed deer.
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